Chemomab Therapeutics Ltd. Restricted Cash, Current
Chemomab Therapeutics Ltd. (CMMB) had Restricted Cash, Current of $0 as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2026-03-23
- 2025-12-31: Restricted Cash, Current $0.00.
- 2025-06-30: Restricted Cash, Current $148.00K.
- 2024-12-31: Restricted Cash, Current $76.00K.
- 2024-06-30: Restricted Cash, Current $74.00K.
| Period end | Restricted Cash, Current |
|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-03-23 |
| 2025-06-30 | $148.00K 6-K · filed 2025-08-14 |
| 2024-12-31 | $76.00K 20-F · filed 2026-03-23 |
| 2024-06-30 | $74.00K 6-K · filed 2024-08-21 |
| 2023-12-31 | $76.00K 20-F · filed 2025-04-04 |
| 2023-06-30 | $74.00K 6-K · filed 2023-08-14 |
| 2023-03-31 | $77.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $77.00K 20-F · filed 2024-03-28 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-20 |
| 2020-03-31 | $126.00K 10-Q · filed 2020-05-07 |